BlackRock Inc. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$964,000
+0.5%
1,190,383
-0.7%
0.00%
Q4 2021$959,000
-30.8%
1,198,962
+2.8%
0.00%
Q3 2021$1,386,000
-24.3%
1,165,942
-1.3%
0.00%
Q2 2021$1,832,000
-81.0%
1,181,599
-70.5%
0.00%
Q1 2021$9,618,000
-14.9%
4,006,960
+4.6%
0.00%
Q4 2020$11,300,000
+110.3%
3,830,466
+9.1%
0.00%
Q3 2020$5,373,000
-38.2%
3,511,724
+1.0%
0.00%
Q2 2020$8,689,000
+31.0%
3,475,302
+6.9%
0.00%
Q1 2020$6,633,000
-34.7%
3,251,569
-1.0%
0.00%
Q4 2019$10,151,000
-6.1%
3,285,147
+1.6%
0.00%
Q3 2019$10,805,000
+8.5%
3,234,877
+4.0%
0.00%
Q2 2019$9,955,000
+26.7%
3,111,073
+13.6%
0.00%
Q1 2019$7,858,000
-31.1%
2,738,109
-3.5%
0.00%
-100.0%
Q4 2018$11,405,000
-14.6%
2,836,932
-0.8%
0.00%0.0%
Q3 2018$13,351,000
-40.2%
2,858,636
+5.3%
0.00%0.0%
Q2 2018$22,338,000
+1302.3%
2,714,335
+610.6%
0.00%
Q1 2018$1,593,000
+27.0%
382,001
-1.1%
0.00%
Q4 2017$1,254,000
+143.5%
386,090
+32.6%
0.00%
Q3 2017$515,000
+66.7%
291,106
-1.1%
0.00%
Q2 2017$309,000
-21.2%
294,225
+6.5%
0.00%
Q1 2017$392,000276,2230.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders